Sinil Pharmaceutical Co. Ltd (012790) — Financial Flexibility Index
Sinil Pharmaceutical Co. Ltd (012790) has a Financial Flexibility Index of 0.16x as of September 2025. Free cash flow of ₩2.84 Billion (operating CF ₩2.62 Billion minus capex ₩213.15 Million) represents 0% of total liabilities (₩18.23 Billion). Check Sinil Pharmaceutical Co. Ltd (012790) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sinil Pharmaceutical Co. Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Sinil Pharmaceutical Co. Ltd across 11 annual periods. For the full cash flow conversion analysis, see Sinil Pharmaceutical Co. Ltd (012790) cash flow conversion.
Annual Financial Flexibility Index for Sinil Pharmaceutical Co. Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for Sinil Pharmaceutical Co. Ltd. Explore how well can Sinil Pharmaceutical Co. Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.61x | ₩31.16 Billion | ₩22.69 Billion | ₩19.36 Billion | ▲ +0.7% |
| 2023 | 1.60x | ₩28.08 Billion | ₩15.15 Billion | ₩17.56 Billion | ▲ +35.8% |
| 2022 | 1.18x | ₩23.02 Billion | ₩13.69 Billion | ₩19.55 Billion | ▲ +25.5% |
| 2021 | 0.94x | ₩14.79 Billion | ₩11.16 Billion | ₩15.78 Billion | ▼ -18.2% |
| 2020 | 1.15x | ₩19.86 Billion | ₩11.06 Billion | ₩17.33 Billion | ▼ -13.7% |
| 2019 | 1.33x | ₩22.04 Billion | ₩12.31 Billion | ₩16.59 Billion | ▼ -15.0% |
| 2018 | 1.56x | ₩17.53 Billion | ₩9.19 Billion | ₩11.22 Billion | ▲ +0.3% |
| 2017 | 1.56x | ₩18.05 Billion | ₩8.67 Billion | ₩11.59 Billion | ▲ +15.4% |
| 2016 | 1.35x | ₩14.66 Billion | ₩12.09 Billion | ₩10.86 Billion | ▼ -20.1% |
| 2015 | 1.69x | ₩15.37 Billion | ₩9.56 Billion | ₩9.09 Billion | ▲ +32.3% |
| 2014 | 1.28x | ₩11.57 Billion | ₩9.33 Billion | ₩9.06 Billion | — |